Citadel Advisors’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Citadel Advisors’s Portfolio REUN Stock Details REUN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,140	Closed	-$9K	–	13994
2022 Q2	$9K	Buy	+2,140	New	+$10.7K	﹤0.01%	12618

Other funds holding REUN

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

OPOWM

One Plus One Wealth Management Jupiter, Florida $232M AUM 28.06% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CAM

Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

HSA

HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return

Citadel Advisors's REUN Position: Q3 2022 in Review

Citadel Advisors sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q3 2022, closing a stake of 6,206 shares — an estimated $26K sold.

Citadel Advisors first reported a position in REUN in Q3 2021 and held it in 4 quarters. The position peaked at $117K in Q4 2021. 27 funds tracked by Wall St. Rank hold REUN as of Q3 2022.

Citadel Advisors reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q3 2022 after selling out during the quarter.
Citadel Advisors sold 6,206 Reunion Neuroscience Inc. Common Shares shares in Q3 2022, an estimated $26K.
Citadel Advisors first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2021 and held it in 4 quarters.
Citadel Advisors's Reunion Neuroscience Inc. Common Shares position peaked at $117K in Q4 2021.
27 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.